Time |
Presentation Title |
Speaker |
Main venue (Ballroom A-B-C) |
Chairman: Shengli Yang, Chingli Hu, Kurt Zatloukal, Bartha Maria Knoppers |
09:00-09:30 |
Welcome |
Shengli Yang |
|
S1: Translational Medicine & Biobank |
Chairman: Shengli Yang, Kurt Zatloukal |
09:30-09:50 |
How Biobanks May Contribute to Innovation |
Kurt Zatloukal |
09:50-10:10 |
The application of Biobanking in Clinic: Biomarkers for Kidney Disease |
Zhihong Liu |
10:10-10:30 |
Biobankonomics: Developing a Sustainable Biospecimen Resource |
Jim Vaught |
10:30-10:45 |
Tea Break & Group Photo |
10:45-11:05 |
Rules of Biospecimen Resource Usage in China |
Yanrong Sun |
11:05-11:25 |
Towards Global Sharing of Genomic and Clinical Data |
Bartha Maria Knoppers |
11:25-11:45 |
Ethics Guideline for Shanghai Clinical Biobank |
Chingli Hu |
11:45-12:00 |
Discussion |
|
S2: Cohort studies for biobanks |
Chairman: Chingli Hu, Bartha Maria Knoppers |
14:00-14:15 |
Shanghai Birth Cohort Study |
Jun Zhang |
14:15-14:30 |
Cohort Study of Kodorrie Biobank |
Zhengming Chen |
14:30-14:45 |
Exploration of Biobank Construction in Taiwan |
Chen-Yang Shen |
14:45-15:00 |
Cohort Study in Columbia University |
Deliang Tang |
15:00-15:15 |
Tea Break |
15:15-15:30 |
Construction of National Cardiovascular Biobank |
Lixin Jiang |
15:30-15:45 |
Gene & Environment: Prospective Cohort Study of Epidemics |
Xu Lin |
15:45-16:00 |
Population-Based Cohort Study in Taizhou |
Xiaofeng Wang |
16:00-16:15 |
Canada Child Birth Cohort Study |
William Fraser |
16:15-16:30 |
Discussion |
Time |
Presentation Title |
Speaker |
>
S3: Disease studies for biobanks |
Chairman: Jim Vaught, Jiayou Chu |
09:00-09:15 |
Role of Government and Society in Biobanking |
Kan Zhang |
09:15-09:30 |
The story of Beijing Biobank |
Peng Wang |
09:30-09:45 |
Exploration of Major Disease-Based Biobank Development in Shanghai |
Peiyong Zheng |
09:45-10:00 |
Implementing a State-of-the-Art Biorepository: The Genome Quebec-Chicoutimi Hospital Experience |
Steve Arsenault |
10:00-10:15 |
Tea Break |
10:15-10:30 |
Biobank & Data Base for Liver Cancer |
Weiping Zhou |
10:30-10:45 |
Study of Susceptibility Genes: the Use of Rheumatism Bio-Samples |
Huji Xu |
10:45-11:00 |
The Biobank of Neurology |
JinSong Wu |
11:00-11:15 |
Cancer Biobank: Facility Management and Services |
Lianhai Zhang |
11:15-11:30 |
Discussion |
|
S4: Quality management systems for biobanking |
Chairman: Geogers Dagher, Yong Zhang |
14:00-14:15 |
Proficiency Testing (PT) Project of ISBER & Biobank |
Andy Zaayange |
14:15-14:30 |
Quality & Value in Biobanks |
Mark Divers |
14:30-14:45 |
Toward the Establishment of Indicators for Evaluating Hospital-Integrated Tumor Biobanks: Main Current Stakes & Limitations |
Paul Holfman |
14:45-15:00 |
Data Quality Control of Biobank |
Weiye Wang |
15:00-15:15 |
Tea Break |
15:15-15:30 |
Quality Perspectives in Biobanking |
Robert Jones |
15:30-15:45 |
Quality Control of Nucleic Acid in Biobank |
Yong Zhang |
15:45-16:00 |
Establishing a US Compliant Biorepository: Challenges & Successes |
Scott Clark |
16:00-16:15 |
Data Management in UK Biobank |
James Brennan |
16:15-16:30 |
Discussion |
16:30-16:40 |
Closing Ceremony |